top
Search terms
Results 1 - 6 of 6 - ordered by :
Epeuropace

For adequate stroke prevention, most patients with non-valvular atrial fibrillation (AF) would need oral anticoagulant therapy (OAC), with either vitamin-K antagonists (VKAs) or non-vitamin-K oral ...

Europace, Editorial, Tatjana S. Potpara, Deirdre A. Lane, Gregory Y.H. Lip

Date : 01/04/2015
Epeuropace

Atrial fibrillation (AF) is the commonest cardiac rhythm disorder and is associated with an increased risk of mortality and morbidity from stroke and thromboembolism. Several NOACs now exist, ...

Europace, Editorial, Torben Bjerregaard Larsen

Date : 01/02/2015
Epeuropace

The fear of bleeding among physicians leads to lack of prescription of oral anticoagulants, and reduces uptake, in patients who may otherwise benefit from them.1,2 Stroke risk is closely related to ...

Europace, Editorial, Pilar Gallego, Gregory Y. H. Lip, Deirdre A. Lane

Date : 01/06/2013 Item size : 150506 bytes
Epeuropace

Discussing heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction: In response to his question about our patient series, all consecutive patients who were ...

EP Europace, Letter to the Editor, Vitaly Sulimov, Elena Okisheva, Dmitry Tsaregorodtsev

Date : 01/01/2013 Item size : 104062 bytes
Epeuropace

Over time many stroke risk stratification schema have been developed, initially with the objective to better define high-risk patients who could be subjected to an inconvenient (and potentially ...

Europace, Editorial, Ron Pisters, Jonas B. Olesen, Gregory Y.H. Lip

Date : 01/01/2012 Item size : 140103 bytes
Epeuropace

Numerous risk factors pre-dispose to atrial fibrillation (AF), namely, hypertension, heart failure, increasing age, diabetes mellitus, and vascular disease.1 Due to the ageing population and the ...

Europace, Editorial, Jonas Bjerring Olesen, Gregory Y.H. Lip, Deirdre A. Lane

Date : 01/08/2011